Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to raise awareness of the uses of different asthma inhalers.

To support the implementation of the updated National Institute for Health and Care Excellence asthma guidelines, NHS England has been engaging with health system partners to coordinate resources and implementation efforts to make sure that patients are on the appropriate treatment regimen, and are using their inhaler at the right time, with the right technique. Updates to patient facing information on asthma management and treatments in line with the updated guidelines are ongoing. For example, the recently published Quality and Outcomes Framework and guidance has been updated to reflect the updated asthma guidelines.

The over-prescribing of reliever inhalers amongst people with asthma has seen a steady fall over the past few years. The percentage of patients on the Quality and Outcomes Framework asthma register who received six or more Short Acting Beta-2 Agonist reliever inhaler prescriptions over the previous 12 months fell from 19.8% in April 2022 to 15.9% in February 2025, a percentage change of 19.8%. Further information is available at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/mi-network-contract-des